Chimeric antigen receptor based on GD2 and application thereof

A technology of chimeric antigen receptors and antigens, which is applied in the field of tumor cell immunotherapy, can solve problems such as difficult to accurately enter tumor tissue, cannot exist in the body for a long time, and increases the difficulty of retreatment, achieving good results and safety. Immunity-stimulating effect, reducing the risk of storms
CN108948211AActive Publication Date: 2018-12-07BEIJING MEIKANG JIMIAN BIOTECH CO LTD
5 Cites 5 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
BEIJING MEIKANG JIMIAN BIOTECH CO LTD
Publication Date
2018-12-07

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a chimeric antigen receptor based on GD2. The chimeric antigen receptor is characterized by being prepared from an antigen combined structural domain, a transmembrane structural domain, a costimulatory signal transduction structural domain, a CD3 zeta signal transduction structural domain and a self-destroying structural domain which are connected in series, wherein the antigen combined structural domain is combined with a surface antigen of a tumor, the surface antigen of the tumor is GD2, the antigen combined structural domain is a single chain antibody for the surface antigen of the tumor GD2, and the self-destroying structural domain is a caspase 9 structural domain. The chimeric antigen receptor is actually applied to a patient suffered from phase IV neuroblastoma expressing a specific target point GD2 of the tumor, is smaller in clinical side effect and higher in safety, can reduce the solid tumor foci effectively, and improves the whole survival rate ofthe patient effectively as presence of GD2-CART can be monitored in the body of the patient for a long time.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to the field of tumor cell immunotherapy, in particular to a GD2-based chimeric antigen receptor and its application, specifically the chimeric antigen receptor T (CAR-T) cell technology based on tumor-specific target GD2 The construction method and its application in anti-tumor therapy. Background technique

[0002] With the development of tumor immunology theory and clinical technology, chimeric antigen receptor T-cell immunotherapy (CAR-T) has become one of the most promising tumor immunotherapy. Generally, a chimeric antigen receptor CAR consists of a tumor-associated antigen-binding region, an extracellular hinge region, a transmembrane region, and an intracellular signal transduction region. Usually, CAR contains the single chain fragment variable (single chain fragment variable, scFv) region of the antibody or the binding domain specific to the tumor associated antigen (tumor associated antigen, TAA), which communi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More